Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ARTHOTCMKTS:CMPDNASDAQ:KERNOTCMKTS:MGTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARTHArch Therapeutics$0.00$0.13$0.16▼$1.57$6K4.024,068 shs8,039 shsCMPDCompuMed$3.40-15.0%$3.55$1.98▼$6.80$5.30M0.122,239 shs1,794 shsKERNAkerna$5.89$0.17▼$6.40$64.92M3.02339,022 shs70,795 shsMGTIMGT Capital Investments$0.00-33.3%$0.00$0.00▼$0.00$684K2.22435,552 shs341 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARTHArch Therapeutics0.00%0.00%+33.33%-99.44%-99.87%CMPDCompuMed-15.00%+4.29%-14.57%-10.53%+71.03%KERNAkerna0.00%0.00%0.00%0.00%0.00%MGTIMGT Capital Investments-33.33%+33.33%+33.33%+33.33%-33.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARTHArch TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACMPDCompuMedN/AN/AN/AN/AN/AN/AN/AN/AKERNAkernaN/AN/AN/AN/AN/AN/AN/AN/AMGTIMGT Capital InvestmentsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARTHArch Therapeutics 0.00N/AN/AN/ACMPDCompuMed 0.00N/AN/AN/AKERNAkerna 0.00N/AN/AN/AMGTIMGT Capital Investments 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARTHArch Therapeutics$80K0.07N/AN/A($2.43) per share0.00CMPDCompuMed$6.22M0.73$0.59 per share5.81$2.49 per share1.37KERNAkerna$13.65M0.00N/AN/A($1.52) per share0.00MGTIMGT Capital Investments$400K1.14N/AN/A($0.01) per share-0.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARTHArch Therapeutics-$6.98MN/A0.00∞N/A-8,257.70%N/A-730.22%8/18/2025 (Estimated)CMPDCompuMed$30K$0.1720.00∞N/A3.13%6.43%4.53%8/12/2025 (Estimated)KERNAkerna-$79.06M-$7.10N/AN/AN/A-339.99%N/A-113.03%N/AMGTIMGT Capital Investments-$6.13MN/A0.00∞N/AN/AN/AN/AN/ALatest MGTI, CMPD, KERN, and ARTH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/17/2025Q2 2024MGTIMGT Capital InvestmentsN/A$0.01N/A$0.01N/A$0.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARTHArch TherapeuticsN/AN/AN/AN/AN/ACMPDCompuMedN/AN/AN/AN/AN/AKERNAkernaN/AN/AN/AN/AN/AMGTIMGT Capital InvestmentsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARTHArch TherapeuticsN/A0.100.01CMPDCompuMed0.182.722.55KERNAkernaN/A0.100.10MGTIMGT Capital InvestmentsN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARTHArch Therapeutics6.91%CMPDCompuMedN/AKERNAkerna21.97%MGTIMGT Capital InvestmentsN/AInsider OwnershipCompanyInsider OwnershipARTHArch Therapeutics4.50%CMPDCompuMed22.00%KERNAkerna1.20%MGTIMGT Capital Investments3.81%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARTHArch Therapeutics104.74 million4.53 millionNot OptionableCMPDCompuMed81.33 million1.03 millionNot OptionableKERNAkerna11210.35 million10.23 millionNo DataMGTIMGT Capital Investments21.14 billion1.10 billionNot OptionableMGTI, CMPD, KERN, and ARTH HeadlinesRecent News About These CompaniesInside MGT Capital Investment: A Transparent Review of Its Investment ApproachMay 7, 2025 | techbullion.comMGT Capital Investments IncNovember 24, 2024 | investing.comQT Imaging Holdings Announces $1M Insiders PIPE InvestmentNovember 13, 2024 | businesswire.comRBC Capital Sticks to Their Buy Rating for Magnite (MGNI)November 8, 2024 | markets.businessinsider.comMGIC Investment’s Strong Q3 Performance and Strategic Capital Return Bolster Buy RatingNovember 7, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Hold Rating on MGIC Investment (MTG)November 7, 2024 | markets.businessinsider.comMGIC Investment Corporation (NYSE:MTG) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | msn.comGreenwich Investment Firm Founder Stole Millions In Clients' Cash: FedsNovember 7, 2024 | msn.comInvestment Thoughts From The Road: Hedge Funds Require New Mental ModelsOctober 31, 2024 | forbes.comMorgan Stanley Private Equity Secondaries Completes Equity Financing Alongside RunTide Capital in ATSG and Evolve IPOctober 31, 2024 | morganstanley.comHyperion Partners Joins MAI Capital ManagementOctober 29, 2024 | businesswire.com(MG) Investment Analysis and AdviceOctober 23, 2024 | news.stocktradersdaily.com(MGPI) Long Term Investment AnalysisOctober 23, 2024 | news.stocktradersdaily.comCitigroup profit beats estimates on investment banking boostOctober 15, 2024 | msn.com(MGMT) Investment ReportOctober 12, 2024 | news.stocktradersdaily.comHow Does MGIC Investment Corp (MTG) Stack Up Against Its Industry Peers?October 11, 2024 | bovnews.comKajeet Announces New Investment from MWP Growth Capital to Accelerate Growth and ExpansionOctober 10, 2024 | tmcnet.comM&G: Decent Performance But Dominated By Other Asset Management OptionsOctober 9, 2024 | seekingalpha.comMGT Capital Investments (OTC:MGTI) Stock, Short Interest ReportOctober 7, 2024 | benzinga.comMarathon Asset Management Provides $210M Loan to Trinity on Ritz-Carlton DallasOctober 4, 2024 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMGTI, CMPD, KERN, and ARTH Company DescriptionsArch Therapeutics OTCMKTS:ARTH$0.0012 0.00 (0.00%) As of 06/20/2025Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.CompuMed OTCMKTS:CMPD$3.40 -0.60 (-15.00%) As of 06/23/2025 03:55 PM EasternCompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.Akerna NASDAQ:KERNAkerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.MGT Capital Investments OTCMKTS:MGTI$0.0004 0.00 (-33.33%) As of 06/23/2025 09:50 AM EasternMGT Capital Investments, Inc. engages in cryptocurrency mining business in the United States. The company owns and manages a bitcoin mining facility in LaFayette, Georgia. It also leases space to third parties and self-mining operations; and provides hosting services for third-party owners of miners. The company was incorporated in 1977 and is headquartered in Lafayette, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
